Search

Search Constraints

You searched for: Author/Creator Forschner, Andrea

Search Results

1. Preferences of German melanoma patients for interferon (IFN) α-2b toxicities (the DeCOG "GERMELATOX survey") versus melanoma recurrence to quantify patients' relative values for adjuvant therapy. Issue 46 (November 2016)

2. Study protocol for a prospective, non-controlled, multicentre clinical study to evaluate the diagnostic accuracy of a stepwise two-photon excited melanin fluorescence in pigmented lesions suspicious for melanoma (FLIMMA study). Issue 12 (19th December 2016)

3. Genetic characterization of advanced conjunctival melanoma and response to systemic treatment. (May 2022)

4. MAPKinase inhibition after failure of immune checkpoint blockade in patients with advanced melanoma – An evaluation of the multicenter prospective skin cancer registry ADOREG. (May 2022)

5. Ipilimumab alone or in combination with nivolumab after progression on anti-PD-1 therapy in advanced melanoma. (April 2017)

7. Chemotherapy after immune checkpoint inhibitor failure in metastatic melanoma: a retrospective multicentre analysis. (February 2022)

8. Pretreatment metastatic growth rate determines clinical outcome of advanced melanoma patients treated with anti-PD-1 antibodies: a multicenter cohort study. Issue 5 (13th May 2021)

9. Toxisch epidermale Nekrolyse bei einem Melanompatienten unter zielgerichteter Therapie mit Encorafenib und Binimetinib. (28th October 2020)

10. QOL-23. TOWARDS PATIENT-REPORTED OUTCOME ASSESSMENT IN THE MOLECULAR TUMOR BOARD – CANCER PATIENTS UNDER TARGETED THERAPY: APP-BASED ASSESSMENT OF PATIENT-REPORTED OUTCOMES (TRACE). (14th November 2022)